NickPowellLab retweeted
We're #hiring new non‑clinical Assistant Professors at @ImperialMed!
Want to join us at @ImperialImmuno?
Make sure to choose ‘Immunology and Inflammation’ as your first preference when applying.
✍️Apply by 11 March 2026.
imperial.ac.uk/jobs/search-j…
NickPowellLab retweeted
A true legend in the field of IBD - your memory will continue to inspire us
Fitting tribute to Prof. Brian Feagan from #ECCO Family
ecco-ibd.eu/publications/in-…
NickPowellLab retweeted
Great progress in recruitment to @ACESO_ASUC this week with 7 patients randomised 📈
2 patients each included by @IbdHull & @imperialcollege teams
1 patient each included by teams from Manchester , Oxford , Leeds
Thank you to participants and 🙏🏼🙏🏼to site teams for all the hard work
We can 👌 do this in 🇬🇧- to make progress in a challenging phenotype of #IBD
#Collaboration
NickPowellLab retweeted
MDR researchers launch a new trial, funded by @GSK, exploring improved vaccine responses in patients with inflammatory bowel disease #IBD (@NickPowellLab @IHepatology)
Find out more ⬇️
imperial.ac.uk/news/271355/n…
NickPowellLab retweeted
Congratulations to @imperialcollege team led by Dr James Alexander & @NickPowellLab for randomising their first patient to @ACESO_ASUC study
And they have done that within 2️⃣4️⃣hours of receiving green light !!!
🚦👏👏
Thanks to the participant and the entire team in particular research nurse Isabel
Many more to come 🤞
NickPowellLab retweeted
Our eagerly awaited #RCT on #JAKis #Upadacitinib in Acute Severe Colitis is now recruiting
The ACESO study @ACESO_ASUC
❇️Double blind placebo controlled
❇️ Upfront #upa + IV steroids Vs Iv steroids + Placebo
❇️Option for entry into rescue sub-studies for non responders
📢📣 3️⃣0️⃣ 🇬🇧 sites
Say hello 👋 for updates if at #BSGLIVE25
NickPowellLab retweeted
Congratulations to Professor Ailsa Hart, IBD Research Lead at St Mark’s. 🌟
At ECCO 2025, Professor Hart presented the latest results of SC guselkumab for moderate to severe active Crohn’s disease at the prestigious Saturday plenary session. Following this, she was awarded the ECCO Global Grant on behalf of a global team of researchers to advance perianal Crohn’s disease research worldwide — a remarkable achievement driving innovation in IBD care.
A fantastic recognition of her dedication to improving patient outcomes! 🙌🏻
NickPowellLab retweeted
Albeit retrospective, an important reassuring data on safety of GLP1s weight reduction in IBD.
I tell my pts that Obesity+associated HTN/diabetes/hyperlipedmia end up killing far more IBD pts than (fortunately very very rare now) death d/t IBD itself.
This is whats at stake !
Safety and Effectiveness of Glucagon-like Peptide-1 receptor agonists in #IBD: our experience @WashUMedIBD @WashUMedGastro led @MalekAyoubMD @SRAnderson121 #SarahCoats @AmJGastro journals.lww.com/ajg/abstrac…
NickPowellLab retweeted
CTLA-4 expressing ILCs modulate mucosal homeostasis in a microbiota dependent manner @NickPowellLab @DrJonLo @Lukuscyte
nature.com/articles/s41467-0…
NickPowellLab retweeted
Moving towards gut dysbiosis testing in cancer immunotherapy resistance.
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome: Cell cell.com/cell/fulltext/S0092…
NickPowellLab retweeted
🏆🌍 @imperialcollege ranked #2 in the world and 1st in the UK and Europe in this 2025 QS @worlduniranking - hubs.ly/Q02BdCrr0
We're delighted that the ranking reflects how we've consistently improved innovation support and entrepreneurship for real-world impact.💙
NickPowellLab retweeted
On #WorldIBDDay, Open Targets project lead @anderson_carl introduces our most ambitious project yet: @OpenIBD!
Today is #WorldIBDDay 🌎
Check out our video with @anderson_carl to discover more about what IBD is and how @OpenIBD aims to find new ways to predict, monitor, and treat it.🔎
@OpenTargets @DrChrisLamb @UniofNewcastle @NewcastleHosps #IBDMythBusting
sanger.ac.uk/news_item/ambit…
NickPowellLab retweeted
Congratulations to all #OurImperial graduates who celebrated their achievements this week @RoyalAlbertHall.🎓
Congratulations also to our award-winners: Dr @LindsayDewa, Prof @p_openshaw, @AglaiaFreccero and Dr @teeoyebamiji!🎉
More 👇
imperial.ac.uk/news/253214/r…
NickPowellLab retweeted
It’s actually still going! Our ceremony starts at 8.15 this evening and you can join us online imperial.ac.uk/students/grad… #OurImperial
Graduation Day 2024 = done ✔️
We hope all your dreams turn into reality as you move on to the next chapter in your life. Whether you are staying with us or departing for new adventures, you will always be part of #OurImperial.
Congratulations to you all! 🥳
NickPowellLab retweeted
Every important IMIBD session @DDWMeeting in one digestible table.
👇🏼👇🏼👇🏼
Getting ready for @DDWMeeting?
Here is our annual sneak peek at our IMIBD programming to help you prepare!
We have focused more than ever on investigator-initiated research as well as novel clinical and basic talks and symposia including:
- 5 state-of-the art basic, translational, and clinical symposia
- 2nd annual IBD late breakers and innovations in IBD research session
- Several dedicated basic and clinical research sessions on Diet, Environment, as well as Pain, Sleep, and Fatigue in IBD
- IBD Distinguished Abstract Plenary Session
- 8 basic/ translational research abstract sessions
- 12 clinical research abstract sessions
- 650+ posters, with poster tours led by expert guides, available.
On behalf of myself and vice chair @AshwinMDIBD as well as our colleagues who spent so many hours, including abstract reviewers, abstract chairs and vice chairs, IMIBD councilors, speakers, research presenters, and dedicated @AmerGastroAssn staff who make it look easy, I hope you enjoy our IBD programming at this year’s DDW.
See you in Washington DC!
NickPowellLab retweeted
A day of discussions on future collaborative working on #humanchallenge studies including the importance of #publicinvolvement @ImperialBRC @NIHRinvolvement
NickPowellLab retweeted
Congrats to @TomasLab_ICL & @imperialcollege colleagues on their @wellcometrust Discovery Grant to advance therapies for metabolic disorders.
"This study will generate the fundamental knowledge necessary to target cholesterol binding sites within GPCRs"
imperial.ac.uk/news/251975/w…
NickPowellLab retweeted
Diana Papp from @ImperialBRC @ImpOrganoid presenting at the World Organoid Research Day (by @OrganoidSphero1) how the Imperial Organoid Facility is supporting #organoid research, disease modelling and studying host-#microbiome interactions.
Great meeting and venue @HinxtonHall
































